{
  "abstract": "Introduction Congenital cytomegalovirus (cCMV) is a common infection at birth with the potential to cause significant and permanent morbidity, most commonly hearing loss. Targeted cCMV testing programmes use hearing loss as an indicator of an infant being at high risk of the infection and thereby can ‘target’ or focus testing on those at greatest risk. Australian and International guidelines recommend that high-risk infants be offered cCMV testing, yet across Australia, a formal testing system does not exist. This paper presents the results of a Western Australian (WA) targeted testing study, detailing its methodology, strengths and challenges to evaluate the feasibility of a targeted cCMV testing programme in WA.Methods A 2-year statewide observational study was conducted in WA from 2020 to 2022. The study used the established universal infant hearing-screening programme to identify infants at high risk of cCMV. Infants who failed their newborn hearing test were recruited to the study and underwent saliva PCR testing. Confirmatory testing was via urine PCR for CMV. This study examines the first 12 months of data.Data collected included the timeliness of testing and results, both integral to effective cCMV diagnosis and treatment. The reasons for high-risk infants being ineligible for testing were explored, and for cCMV-positive infants, the timeliness of reviews and investigations was evaluated.Results During the study period, 212 infants at high risk of cCMV were identified. Of these, 134 (63%) met inclusion criteria and 103 (77%) consented to participate. The study achieved complete and timely cCMV testing, along with timely review and investigation of cCMV-positive infants. Barriers to testing eligibility among high-risk infants (n=78) were assessed to inform strategies to improve testing access.Conclusions WA currently lacks a structured, targeted cCMV testing programme, resulting in missed diagnosis and early intervention opportunities for high-risk infants. The study findings indicate that a structured, targeted cCMV testing programme is feasible and would ensure affected children receive care that aligns with national and international standards.",
  "authors": [
    {
      "affiliations": [
        "Department of Otolaryngology, Perth Children’s Hospital, Perth, Western Australia, Australia",
        "The University of Western Australia Medical School, Perth, Western Australia, Australia"
      ],
      "name": "Allison Reid"
    },
    {
      "affiliations": [
        "The University of Western Australia Medical School, Perth, Western Australia, Australia",
        "Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia, Australia",
        "Department of Infectious Disease, Perth Children’s Hospital, Perth, Western Australia, Australia",
        "University of New South Wales, Sydney, New South Wales, Australia"
      ],
      "name": "Asha C Bowen"
    },
    {
      "affiliations": [
        "Audiology Department, Perth Children’s Hospital, Perth, Western Australia, Australia",
        "School of Medicine, Curtin University, Perth, Western Australia, Australia",
        "Ear and Hearing Health, Telethon Kids Institute, Nedlands, Western Australia, Australia"
      ],
      "name": "Christopher G Brennan-Jones"
    },
    {
      "affiliations": [
        "Department of Otolaryngology, Perth Children’s Hospital, Perth, Western Australia, Australia",
        "The University of Western Australia Medical School, Perth, Western Australia, Australia"
      ],
      "name": "Jafri Kuthubutheen"
    }
  ],
  "title": "Is targeted cytomegalovirus testing of infants feasible in Western Australia? An observational study",
  "uid": "244046f7-f3ea-5c15-9e83-669b57509939"
}